Found: 9
Select item for more details and to access through your institution.
Economic evaluation of trastuzumab in HER2-positive early breast cancer in Indonesia: A cost-effectiveness analysis.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0304483
- By:
- Publication type:
- Article
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 4, p. 689, doi. 10.1007/s10198-023-01617-3
- By:
- Publication type:
- Article
Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Budget and health impact of switching eligible patients with atrial fibrillation to lower-dose dabigatran.
- Published in:
- Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2247719
- By:
- Publication type:
- Article
Facing problems in radiotherapy for breast cancer patients in Yogyakarta, Indonesia: A cohort retrospective study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8851, doi. 10.1002/cam4.5634
- By:
- Publication type:
- Article
Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0222658
- By:
- Publication type:
- Article
Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 9, p. 929, doi. 10.1007/s40273-024-01388-6
- By:
- Publication type:
- Article
A Systematic Review of Health-Related Quality of Life in Women with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 4, p. 511, doi. 10.1007/s41669-024-00478-7
- By:
- Publication type:
- Article
Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice